Idiopathic normal pressure hydrocephalus (iNPH) is often misdiagnosed as Alzheimer’s disease (AD) due to overlapping pathophysiology and similar imaging characteristics, including ventricular enlargement and increased white matter lesions (WMLs).
Objective:
To compare the extent and distribution of WMLs directly between iNPH and AD and examine the association with underlying pathophysiology.
Methods:
Twelve patients with iNPH (mean age: 78.08 years; 5 females), 20 with AD (mean age: 75.40 years; 13 females), and 10 normal cognition (NC) participants (mean age: 76.60 years; 7 females) were recruited. The extent and distribution of WMLs and the lateral ventricular volume (LV-V) were evaluated on MRI using voxel-based morphometry analysis. Concentrations of cerebrospinal fluid biomarkers, such as amyloid-β protein (Aβ)42, Aβ40, Aβ38, and tau species, were also measured. Risk factors for small vessel disease (SVD) were assessed by blood examination and medical records.
Results:
The periventricular WML volume (PWML-V) and deep WML volume (DWML-V) were significantly larger in iNPH than in AD and NC. The DWML-V was dominant in iNPH, while the PWML-V was dominant in AD and NC. GM-V was significantly smaller in AD than in iNPH and NC. The LV-V positively correlated with WML-V in all participants. There was a significant negative correlation between LV-V and Aβ38 in iNPH. Furthermore, there was no significant difference in SVD risk factors between the groups.
Conclusion:
The differences in the extent and distribution of WMLs between iNPH and AD, especially predominance of DWML-V over PWML-V in iNPH, may reflect decreased fluid and Aβ clearance.
HiraokaK, MeguroK, MoriE (2008) Prevalence of idiopathic normal-pressure hydrocephalus in the elderly population of a Japanese rural community. Neurol Med Chir (Tokyo)48, 197–199; discussion 199–200.
2.
AdamsRD, FisherCM, HakimS, OjemannRG, SweetWH (1965) Symptomatic occult hydrocephalus with “normal” cerebrospinal-fluid pressure. a treatable syndrome. N Engl J Med273, 117–126.
3.
NassarBR, LippaCF (2016) Idiopathic normal pressure hydrocephalus: A review for general practitioners. Gerontol Geriatr Med2, 2333721416643702.
4.
HebertLE, ScherrPA, BieniasJL, BennettDA, EvansDA (2003) Alzheimer disease in the US population: Prevalence estimates using the 2000 census. Arch Neurol60, 1119–1122.
5.
EvansWA (1942) An encephalographic ratio for estimating ventricular enlargement and cerebral atrophy. Arch Neurol Psychiatr47, 931–937.
6.
ShermanJL, CitrinCM, GangarosaRE, BowenBJ (1987) The MR appearance of CSF flow in patients with ventriculomegaly. AJR Am J Roentgenol148, 193–199.
7.
IshikawaM, OowakiH, TakezawaM, TakenakaT, YamadaS, YamamotoK, OkamotoS (2016) Disproportionately enlarged subarachnoid space hydrocephalus in idiopathic normal-pressure hydrocephalus and its implication in pathogenesis. Acta Neurochir Suppl122, 287–290.
8.
BrixMK, WestmanE, SimmonsA, RingstadGA, EidePK, Wagner-LarsenK, PageCM, VitelliV, BeyerMK (2017) The Evans’ Index revisited: New cut-off levels for use in radiological assessment of ventricular enlargement in the elderly. Eur J Radiol95, 28–32.
9.
WilliamsMA, MalmJ (2016) Diagnosis and treatment of idiopathic normal pressure hydrocephalus. Continuum (Minneap Minn)22, 579–599.
10.
KimMJ, SeoSW, LeeKM, KimST, LeeJI, NamDH, NaDL (2011) Differential diagnosis of idiopathic normal pressure hydrocephalus from other dementias using diffusion tensor imaging. AJNR Am J Neuroradiol32, 1496–1503.
11.
ReevesBC, KarimyJK, KundishoraAJ, MestreH, CerciHM, MatoukC, AlperSL, LundgaardI, NedergaardM, KahleKT (2020) Glymphatic system impairment in Alzheimer’s disease and idiopathic normal pressure hydrocephalus. Trends Mol Med26, 285–295.
12.
AspelundA, AntilaS, ProulxST, KarlsenTV, KaramanS, DetmarM, WiigH, AlitaloK (2015) A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J Exp Med212, 991–999.
13.
IliffJJ, WangM, LiaoY, PloggBA, PengW, GundersenGA, BenvenisteH, VatesGE, DeaneR, GoldmanSA, NagelhusEA, NedergaardM (2012) A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Sci Transl Med4, 147ra111.
14.
Tarasoff-ConwayJM, CarareRO, OsorioRS, GlodzikL, ButlerT, FieremansE, AxelL, RusinekH, NicholsonC, ZlokovicBV, FrangioneB, BlennowK, MénardJ, ZetterbergH, WisniewskiT, de LeonMJ (2015) Clearance systems in the brain-implications for Alzheimer disease. Nat Rev Neurol11, 457–470.
ValotassiouV, MalamitsiJ, PapatriantafyllouJ, DardiotisE, TsougosI, PsimadasD, AlexiouS, HadjigeorgiouG, GeorgouliasP (2018) SPECT and PET imaging in Alzheimer’s disease. Ann Nucl Med32, 583–593.
19.
WellerRO, HawkesCA, KalariaRN, WerringDJ, CarareRO (2015) White matter changes in dementia: Role of impaired drainage of interstitial fluid. Brain Pathol25, 63–78.
20.
GouwAA, SeewannA, van der FlierWM, BarkhofF, RozemullerAM, ScheltensP, GeurtsJJ (2011) Heterogeneity of small vessel disease: A systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatry82, 126–135.
21.
KimKW, MacFallJR, PayneME (2008) Classification of white matter lesions on magnetic resonance imaging in elderly persons. Biol Psychiatry64, 273–280.
22.
WardlawJM, Valdés HernándezMC, Muñoz-ManiegaS (2015) What are white matter hyperintensitiesmade of? Relevance to vascular cognitive impairment. J Am HeartAssoc4, 001140.
23.
BarberR, ScheltensP, GholkarA, BallardC, McKeithI, InceP, PerryR, O’BrienJ (1999) White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer’s disease, vascular dementia, and normal aging. J Neurol Neurosurg Psychiatry67, 66–72.
24.
McAleeseKE, WalkerL, GrahamS, MoyaELJ, JohnsonM, ErskineD, CollobySJ, DeyM, Martin-RuizC, TaylorJP, ThomasAJ, McKeithIG, De CarliC, AttemsJ (2017) Parietal white matter lesions in Alzheimer’s disease are associated with cortical neurodegenerative pathology, but not with small vessel disease. Acta Neuropathol134, 459–473.
25.
PietroboniAM, ScarioniM, CarandiniT, BasilicoP, CadioliM, GiuliettiG, ArighiA, CaprioliM, SerraL, SinaC, FenoglioC, GhezziL, FumagalliGG, De RizMA, CalviA, TriulziF, BozzaliM, ScarpiniE, GalimbertiD (2018) CSF β-amyloid and white matter damage: A new perspective on Alzheimer’s disease. J Neurol Neurosurg Psychiatry89, 352–357.
26.
KandelBM, AvantsBB, GeeJC, McMillanCT, ErusG, DoshiJ, DavatzikosC, WolkDA (2016) White matter hyperintensities are more highly associated with preclinical Alzheimer’s disease than imaging and cognitive markers of neurodegeneration. Alzheimers Dement (Amst)4, 18–27.
27.
McAleeseKE, FirbankM, DeyM, CollobySJ, WalkerL, JohnsonM, BeverleyJR, TaylorJP, ThomasAJ, O’BrienJT, AttemsJ (2015) Cortical tau load is associated with white matter hyperintensities. Acta Neuropathol Commun3, 60.
28.
KraussJK, RegelJP, VachW, OrszaghM, JünglingFD, BohusM, DrosteDW (1997) White matter lesions in patients with idiopathic normal pressure hydrocephalus and in an age-matched control group: A comparative study. Neurosurgery40, 491–495.
29.
MurataT, HandaH, MoriK, NakanoY (1981) The significance of periventricular lucency on computed tomography: Experimental study with canine hydrocephalus. Neuroradiology20, 221–227.
30.
AkiguchiI, IshiiM, WatanabeY, WatanabeT, KawasakiT, YagiH, ShiinoA, ShirakashiY, KawamotoY (2008) Shunt-responsive parkinsonism and reversible white matter lesions in patients with idiopathic NPH. J Neurol255, 1392–1399.
31.
YokotaH, VijayasarathiA, CekicM, HirataY, LinetskyM, HoM, KimW, SalamonN (2019) Diagnostic performance of glymphatic system evaluation using diffusion tensor imaging in idiopathic normal pressure hydrocephalus and mimickers. Curr Gerontol Geriatr Res2019, 5675014.
32.
RingstadG, VatneholSAS, EidePK (2017) Glymphatic MRI in idiopathic normal pressure hydrocephalus. Brain140, 2691–2705.
33.
RingstadG, ValnesLM, DaleAM, PrippAH, VatneholSS, EmblemKE, MardalKA, EidePK (2018) Brain-wide glymphatic enhancement and clearance in humans assessed with MRI. JCI Insight3, e121537.
34.
KurodaT, HonmaM, MoriY, FutamuraA, SugimotoA, YanoS, KinnoR, MurakamiH, OnoK (2020) Increased presence of cerebral microbleeds correlates with ventricular enlargement and increased white matter hyperintensities in Alzheimer’s disease. Front Aging Neurosci12, 13.
35.
MoriE, IshikawaM, KatoT, KazuiH, MiyakeH, MiyajimaM, NakajimaM, HashimotoM, KuriyamaN, TokudaT, IshiiK, KaijimaM, HirataY, SaitoM, AraiH, JapaneseSociety of Normal Pressure Hydrocephalus (2012) Guidelines for management of idiopathic normal pressure hydrocephalus: Second edition. Neurol Med Chir (Tokyo)52, 775–809.
36.
McKhannGM, KnopmanDS, ChertkowH, HymanBT, JackCRJr., KawasCH, KlunkWE, KoroshetzWJ, ManlyJJ, MayeuxR, MohsRC, MorrisJC, RossorMN, ScheltensP, CarrilloMC, ThiesB, WeintraubS, PhelpsCH (2011) The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement7, 263–269.
37.
FolsteinMF, FolsteinSE, McHughPR (1975) ‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res12, 189–198.
38.
FazekasF, KleinertR, OffenbacherH, SchmidtR, KleinertG, PayerF, RadnerH, LechnerH (1993) Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology43, 1683–1689.
39.
FazekasF, ChawlukJB, AlaviA, HurtigHI, ZimmermanRA (1987) MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. AJR Am J Roentgenol149, 351–356.
40.
SyaifullahAH, ShiinoA, KitaharaH, ItoR, IshidaM, TanigakiK (2020) Machine learning for diagnosis of AD and prediction of MCI progression from brain MRI using brain anatomical analysis using diffeomorphic deformation. Front Neurol11, 576029.
WangYL, ChenW, CaiWJ, HuH, XuW, WangZT, CaoXP, TanL, YuJT; Alzheimer’s Disease Neuroimaging Initiative (2020) Associations of white matter hyperintensities with cognitive decline: A longitudinal study. J Alzheimers Dis73, 759–768.
43.
JacobsHI, ClerxL, GronenschildEH, AaltenP, VerheyFR (2014) White matter hyperintensities are positively associated with cortical thickness in Alzheimer’s disease. J Alzheimers Dis39, 409–422.
44.
HořínekD, Štěpán-BuksakowskaI, SzabóN, EricksonBJ, TóthE, ŠulcV, BenešV, VránaJ, HortJ, NimskyC, MohaplM, RočekM, VécseiL, KincsesZT (2016) Difference in white mattermicrostructure in differential diagnosis of normal pressurehydrocephalus and Alzheimer’s disease. Clin Neurol Neurosurg140, 52–59.
45.
BrinkerT, StopaE, MorrisonJ, KlingeP (2014) A new look atcerebrospinal fluid circulation. Fluids Barriers CNS11, 10.
46.
JeppssonA, WikkelsöC, BlennowK, ZetterbergH, ConstantinescuR, RemesAM, HerukkaSK, RauramaaT, NaggaK, LeinonenV, TullbergM (2019) CSF biomarkers distinguish idiopathic normal pressurehydrocephalus from its mimics. J Neurol Neurosurg Psychiatry90, 1117–1123.
47.
HanssonO, LehmannS, OttoM, ZetterbergH, LewczukP (2019) Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s disease. Alzheimers Res Ther11, 34.
48.
JanelidzeS, ZetterbergH, MattssonN, PalmqvistS, VandersticheleH, LindbergO, van WestenD, StomrudE, MinthonL, BlennowK, Swedish BioFINDER study group, HanssonO (2016) CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: Better diagnostic markers of Alzheimer disease. Ann Clin Transl Neurol3, 154–165.
49.
van WestenD, LindqvistD, BlennowK, MinthonL, NäggaK, StomrudE, ZetterbergH, HanssonO (2016) Cerebral white matter lesions - associations with Aβ isoforms and amyloid PET. Sci Rep6, 20709.
50.
RoseboroughA, RamirezJ, BlackSE, EdwardsJD (2017) Associations between amyloid β and white matter hyperintensities: A systematic review. Alzheimers Dement13, 1154–1167.
51.
SoldanA, PettigrewC, ZhuY, WangMC, MoghekarA, GottesmanRF, SinghB, MartinezO, FletcherE, DeCarliC, AlbertM, BIOCARD Research Team (2020) White matter hyperintensities and CSF Alzheimer disease biomarkers in preclinical Alzheimer disease. Neurology94, e950–e960.
